Mrs. Letty Lee Faller, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 W 64th St, Richfield, MN 55423 Phone: 612-798-8329 Fax: 612-861-6050 |
Marianne Cartwright, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 W 64th St, Richfield, MN 55423 Phone: 612-767-7904 |
Kristina Fiscus Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 7727 Portland Ave, Richfield, MN 55423 Phone: 612-861-1691 |
Jennifer Jordan Gibson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 W 64th St, Richfield, MN 55423 Phone: 612-767-7958 |
Maria Ann Hone, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7727 Portland Ave, Richfield, MN 55423 Phone: 612-861-1691 |
Mary Elyse Kelly, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6625 Lyndale Ave S Ste 430, Richfield, MN 55423 Phone: 952-285-2840 |
Ms. Karin Kongsjord Nikula, EDD/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7727 Portland Ave, Richfield, MN 55423 Phone: 612-455-0304 |
Merryn Skarphol-pellizzer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 W 64th St, Richfield, MN 55423 Phone: 612-767-7931 |
Mrs. Sara Lorraine Fox, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7727 Portland Ave, Richfield, MN 55423 Phone: 612-455-0304 Fax: 612-861-0186 |
Mrs. Joyce Johnson Anderson, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 W 64th St, Richfield, MN 55423 Phone: 612-400-6122 |
Katie Ann Malone Kroulik, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7727 Portland Ave, Richfield, MN 55423 Phone: 612-861-1691 |
Jennifer Anderson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6625 Lyndale Ave S Ste 430, Richfield, MN 55423 Phone: 952-285-2840 Fax: 952-285-2830 |
Mrs. Noelle Theresa Everts, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6519 Nicollet Ave, Suite 301, Richfield, MN 55423 Phone: 612-243-1514 Fax: 612-869-1778 |
Katherine Kolbow Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2400 W 64th St, Richfield, MN 55423 Phone: 952-767-6786 |
Lindsey Reinsel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6625 Lyndale Ave S, Richfield, MN 55423 Phone: 952-285-2840 |
News Archive
Ancient human microbiomes are under the microscope for what they tell scientists about the people of long ago. A new study published in the journal Frontiers in Ecology and Evolution in February 2020 shows that the gut microbiome can adapt to new bacterial exposures, which allows humans to migrate to new locations successfully.
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.
WIn a study of children with mild, persistent asthma, scientists found that acetaminophen was tolerated without the worsening of asthma, when compared with ibuprofen use.
A new study finds that not only low but also high maternal thyroid hormone levels during early pregnancy may significantly lower the infant's IQ later in childhood. The study results, which will be presented Thursday at the Endocrine Society's 97th annual meeting in San Diego, suggest that the common practice of treating pregnant women who have mild thyroid hormone deficiency may pose unexpected risks to the developing baby's brain.
NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company's novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.
› Verified 5 days ago